search
Back to results

Pre- and Apnoeic Oxygenation for RSI in ED (Pre-AeRATE)

Primary Purpose

Intubation, Oxygen Inhalation Therapy

Status
Completed
Phase
Not Applicable
Locations
Singapore
Study Type
Interventional
Intervention
High-flow nasal cannulae (HFNC) oxygenation
Non-rebreather mask and standard nasal cannula
Sponsored by
National University Hospital, Singapore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Intubation focused on measuring high flow oxygenation, rapid sequence intubation

Eligibility Criteria

21 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH)

Exclusion Criteria:

  • Patients with "do-not-resuscitate" orders
  • Crash, awake or delayed sequence intubations
  • Patients requiring non-invasive positive pressure ventilation
  • Cardiac arrest
  • Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement
  • Vulnerable patient populations (e.g. pregnant women, prisoners)

Sites / Locations

  • National University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Control

Arm Description

High-flow nasal cannula oxygenation at 60L/min for pre-oxygenation and apnoeic oxygenation

Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min

Outcomes

Primary Outcome Measures

Lowest SpO2 achieved during first intubation attempt
Lowest SpO2 achieved during first intubation attempt which is defined as first attempt to insert endotracheal tube into oropharynx

Secondary Outcome Measures

Number of attempts at intubation
Number of attempts until successful intubation as indicated by detection of quantitative ETCO2
Safe apnoea time during intubation
Duration of apnoea where SpO2 remains ≥ 90%
Incidence of SpO2 < 90%
Incidence of SpO2 < 90% during apnoea
Peri-intubation adverse events
Peri-intubation adverse events defined as hypotension, hypertension, tachycardia, bradycardia, regurgitation, aspiration, cardiac arrhythmia, cardiac arrest during RSI, oropharynx or dental trauma
Length of time to successful intubation
Time taken from induction to successful intubation attempt

Full Information

First Posted
January 1, 2018
Last Updated
March 2, 2021
Sponsor
National University Hospital, Singapore
Collaborators
Ng Teng Fong General Hospital, Singapore Clinical Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03396094
Brief Title
Pre- and Apnoeic Oxygenation for RSI in ED
Acronym
Pre-AeRATE
Official Title
Pre- and Apnoeic High Flow Oxygenation for RApid Sequence Intubation in The Emergency Department (Pre-AeRATE): a Multicentre Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
May 7, 2018 (Actual)
Primary Completion Date
January 1, 2020 (Actual)
Study Completion Date
July 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National University Hospital, Singapore
Collaborators
Ng Teng Fong General Hospital, Singapore Clinical Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Critically ill patients may need support for breathing by means of intubation, which is placement of a breathing tube into the windpipe. Rapid sequence intubation (RSI) is a method commonly used and is performed by administering medications to induce coma and muscle paralysis, followed by intubation to allow the ventilator to provide oxygen into the lungs. This procedure may be filled with potential complications. During RSI, the patient stops spontaneous breathing after medically induced muscle paralysis occurs. Adequate oxygenation before and during paralysis is crucial to increase the reserves and prolong the time that oxygen levels in the blood remain above 90%, called the safe apnoea period. If the oxygen reserves are insufficient, the blood oxygen level will drop and can lead to permanent brain damage or even death. This study aims to explore if delivering high-flow humidified oxygen at 60L/min via the nostrils would be superior to current methods of mask ventilation at 15L/min and nasal cannula at 15L/min, before and during paralysis respectively. If successful, this new method would allow for a longer safe apnoeic period and increase the chances for doctors to perform intubation successfully without the blood oxygen dropping below 90%.
Detailed Description
Maintaining adequate oxygenation during rapid sequence intubation (RSI) is imperative to prevent peri-intubation adverse events that can lead to increased duration of hospital and intensive care unit stay, or prolonged vegetative state requiring long-term institutionalisation. Preliminary data from our emergency department (ED) airway registry revealed that 15% of patients experienced desaturation during intubation despite employing current best practices during RSI. In this multicentre randomised controlled trial in the ED, we aim to test the hypothesis that use of humidified high flow oxygenation via nasal cannula (HFNC) at 60L/min maintains higher oxygen saturation compared with current usual care using non-rebreather mask for preoxygenation and provides superior apnoeic oxygenation compared to the typical practice of 15L/min via standard nasal cannula. The main goal of the study would be to improve on the lowest oxygen saturation during intubation, and thereby increase the safe apnoeic time during RSI. We plan to enrol adult patients who require rapid sequence intubation due to medical, surgical or traumatic conditions in the EDs of National University Hospital and Ng Teng Fong General Hospital. Eligible patients will undergo block randomisation at equal ratio into 2 possible treatment combinations of pre-oxygenation and apnoeic oxygenation. The primary endpoint will be the lowest oxygen saturation achieved from time of administration of paralytic agent until quantitative end-tidal carbon dioxide is detected for the first intubation attempt. Higher failure rates for intubation in unfasted patients in the ED compared to fasted patients in elective settings increase the risk of aspiration if re-oxygenation is required with bag-valve-mask ventilation. Prolongation of safe apnoea time through maintenance of oxygen saturation above 90% using HFNC oxygenation during RSI could potentially change current clinical practice, improve standard of care and translate to better outcomes for patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intubation, Oxygen Inhalation Therapy
Keywords
high flow oxygenation, rapid sequence intubation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study consists of 2 arms (intervention and control) of parallel design. The intervention arm will receive high flow nasal cannula (HFNC) oxygenation at 60L/min for pre- and apnoeic oxygenation while the control arm will receive pre-oxygenation via non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
192 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
High-flow nasal cannula oxygenation at 60L/min for pre-oxygenation and apnoeic oxygenation
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min
Intervention Type
Device
Intervention Name(s)
High-flow nasal cannulae (HFNC) oxygenation
Other Intervention Name(s)
AIRVO™ 2 Humidifier with Integrated Flow Generator
Intervention Description
Delivery of 60L/min of supplemental oxygen for pre-oxygenation and apnoeic oxygenation during rapid sequence intubation using the AIRVO™ 2 Humidifier with Integrated Flow Generator (Fisher & Paykel Healthcare, Auckland, New Zealand)
Intervention Type
Device
Intervention Name(s)
Non-rebreather mask and standard nasal cannula
Intervention Description
Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min
Primary Outcome Measure Information:
Title
Lowest SpO2 achieved during first intubation attempt
Description
Lowest SpO2 achieved during first intubation attempt which is defined as first attempt to insert endotracheal tube into oropharynx
Time Frame
From time of administration of paralytic agent until quantitative ETCO2 is detected post-intubation up to 45 minutes
Secondary Outcome Measure Information:
Title
Number of attempts at intubation
Description
Number of attempts until successful intubation as indicated by detection of quantitative ETCO2
Time Frame
Number of attempts required until successful intubation up to 45 minutes or termination of procedure, whichever is earlier
Title
Safe apnoea time during intubation
Description
Duration of apnoea where SpO2 remains ≥ 90%
Time Frame
From start of paralysis to time when SpO2 drops to less than 90% up to 45 minutes
Title
Incidence of SpO2 < 90%
Description
Incidence of SpO2 < 90% during apnoea
Time Frame
From start of paralysis to successful intubation up to 45 minutes
Title
Peri-intubation adverse events
Description
Peri-intubation adverse events defined as hypotension, hypertension, tachycardia, bradycardia, regurgitation, aspiration, cardiac arrhythmia, cardiac arrest during RSI, oropharynx or dental trauma
Time Frame
From induction to 15 minutes after intubation
Title
Length of time to successful intubation
Description
Time taken from induction to successful intubation attempt
Time Frame
From induction until successful intubation as confirmed by detection of quantitative ETCO2 up to 45 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH) Exclusion Criteria: Patients with "do-not-resuscitate" orders Crash, awake or delayed sequence intubations Patients requiring non-invasive positive pressure ventilation Cardiac arrest Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement Vulnerable patient populations (e.g. pregnant women, prisoners)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mui Teng Chua, MBBS, MPH
Organizational Affiliation
National University Hospital, Singapore
Official's Role
Principal Investigator
Facility Information:
Facility Name
National University Hospital
City
Singapore
Country
Singapore

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30947740
Citation
Chua MT, Khan FA, Ng WM, Lu Q, Low MJW, Yau YW, Punyadasa A, Kuan WS. Pre- and Apnoeic high flow oxygenation for RApid sequence intubation in The Emergency department (Pre-AeRATE): study protocol for a multicentre, randomised controlled trial. Trials. 2019 Apr 4;20(1):195. doi: 10.1186/s13063-019-3305-8.
Results Reference
derived

Learn more about this trial

Pre- and Apnoeic Oxygenation for RSI in ED

We'll reach out to this number within 24 hrs